No Result
View All Result
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Analyst News
  • Earnings News
  • Insider Trades
  • Dividend Stocks
Subscribe Now
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports
No Result
View All Result
HOME MARKET SECTORS STOCK BUYS INSIDER TRADES DIVIDEND STOCKS
     BACK TO MENU Technology Health Finance Consumer Commercial Services Electronic Communications Transportation Utilities Minerals Other Sectors Electric Vehicles Pot Stock 5G Stock Crypto
dailystockmovers.com
No Result
View All Result

Krystal Biotech Health Tickers Trending Now (Symbols include KRYS, BBIO, GERN, ITOS, OPRX)

by Staff Editor
May 31, 2023
in Health Health Technology Health Services Watchlist 

Just hitting the wires on HealthTechMovers.com, these 5 consumer stocks just received "Buy" ratings. These are very volatile stocks so please do your own research before you make any investments. While we may list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers.

DailyStockMovers.com is also looking into these tickers DAWN, COGT, RMD, BSX, RACE, RTX.

Krystal Biotech, KRYS
Krystal Biotech (KRYS) has seen a 43.43% increase in price over the past month and a 47.09% increase in price over the past three months, and a 54.98% increase since the 6 month mark, leading to a market cap of $3.11B. Analysts are giving this stock a strong-buy consensus with a target price of $141.00, giving an upside of 22.12%. Volume has been high lately with an average 10 day volume of 566,193, and if the bullish analyst consensus continues, this stock is likely to continue to trend upwards.

Click here to get the full story on KRYS stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

BridgeBio Pharma, BBIO
BridgeBio Pharma (BBIO) has seen an overall decrease of 5.30% in price over the last month, and an increase of 20.40% over the past three months, and an increase of 46.74% since the 6 month mark, giving it a market cap of $2.21B. Analysts are giving this stock a strong buy consensus and setting a target price of $29.57, giving an upside of 118.39%. Volume has been high lately with 1,317,725 average 10 day volume, and with the strong consensus of analysts this stock could continue to be bullish.

Click here to get the full story on BBIO stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Geron, GERN
Geron (GERN) has an average volume of 5,372,493, with a one month gain of 32.11%, a three month gain of 16.91%, and a six month gain of 40.09%, leading to a market cap of $1.65B. Analysts have a strong buy consensus on this stock setting a target price of $5.00, giving it a realistic 50.60% upside. Volume has increased slightly lately and the positive analyst sentiment suggests that this stock could continue to trend upwards in the near future.

Click here to get the full story on GERN stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

iTeos Therapeutics, ITOS
iTeos Therapeutics (ITOS) has recently seen a decrease of 8.92% in price over the last day. The stock has seen a one month gain of 31.37%, a three month gain of 1.92%, and a six month loss of 10.42%, bringing it to a market cap of $645.54M. Analysts have returned a moderate buy consensus and have set a target price of $39.67, offering an impressive 141.30% upside. Volume has been low lately, but this could be offset by the bullish analyst consensus and the stock could continue to show potential gains in the future.

Click here to get the full story on ITOS stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

OptimizeRx, OPRX
OptimizeRx (OPRX) has a market cap of $243.38M and an average 10 day volume of 124,555. Over the past month, this stock has seen a negative 5.46% change in its price, a negative 20.39% change over the past three months, and negative 32.62% change since the 6 month mark. Analysts have given this stock a strong-buy consensus and set a target price of $21.50, offering investors an upside of 56.93%. With its low price target upside and the analysts consensus, this stock is likely to continue to trend downwards.

Click here to get the full story on OPRX stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------


The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.

We
appreciate your continued interest in our analyst ratings email newsletter and we hope that you remain informed on all the latest financial developments and news. We look forward to providing you with more comprehensive analyst ratings and analysis in the near future.

Thank
you and have a great day.


DailyStockMovers.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to DailyStockMovers.com.

Tags: health stocks KRYS stock price Krystal Biotech stock price KRYS news Krystal Biotech stock news 

Related Posts

From Shrinkflation to Economic Collapse: Is a Financial Storm Brewing?

Oct 13, 2024

The Week Ahead: Earnings Season Kicks Off and Retail Sales in Focus

Oct 13, 2024
Dividend 

4 Stocks Up 30%+ in 5 Days: EV, Lithium, and Tech Leaders

Oct 09, 2024
UP Fintech Holding Limited stock TIGR TIGR price target Financial Services stock watchlist Financial Services stocks 

4 Soaring Stocks Up Over 46% in 5 Days

Oct 04, 2024
Dividend 

3 Dividend Stocks Up Over 30% in the Last Week

Oct 04, 2024

Massive "Backdoor" Pre-IPO Play in Musk's $100 Billion Starlink?

Oct 03, 2024
Next Post
Canadian regulator rejects Enbridge plan to contract oil pipeline space

Canadian regulator rejects Enbridge plan to contract oil pipeline space

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

No Result
View All Result

Screener data might be 15 minutes delayed from the real time.

  • Newsletters
  • Advertise with Us
  • About Us
  • Feedback/Contact Us
  • Email Notice, Data Use and DMCA
  • Privacy Policy
  • Terms of Use and Disclaimer
  • 17B List of Disclosures
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This site contains articles and videos are offered for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation or be relied upon as personalized investment advice. We are a financial publisher. We are not financial advisors and cannot give personalized advice. There is a risk of loss in all trading, and you may lose some or all of your original investment. Results presented are not typical. Never make any investment or trade with our first consulting with your investment advisor and after doing your own due diligence. This webpage and website is protected by copyright laws of the United states and international treaties.

©2021 Sandpiper Marketing Group
PO Box 407. Mt. Mourne, NC 28123-0407

  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports

©2021 Sandpiper Marketing Group

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In